Review article: practical management of inflammatory bowel disease patients taking immunomodulators.
about
Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative dataUse of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Lost in translation: helping patients understand the risks of inflammatory bowel disease therapy.Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendationsThe effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patientsEldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study.Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis.The fundamental basis of inflammatory bowel disease.Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chrClinical predictors of thiopurine-related adverse events in Crohn's disease.Management of inflammatory bowel diseases in Eastern EuropeSystematic review: managing anaemia in Crohn's disease.Treatment of inflammatory bowel disease: a review of medical therapy.Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease.Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease.The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?Specific considerations in the treatment of pediatric inflammatory bowel disease.Mesalamine with MMX technology for the treatment of ulcerative colitis.Common Pitfalls in Management of Inflammatory Bowel Disease.Weight and Body Composition Compartments do Not Predict Therapeutic Thiopurine Metabolite Levels in Inflammatory Bowel Disease.Second Korean guidelines for the management of ulcerative colitis.Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops.Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Maintenance therapy options for ulcerative colitis.The safety of treatment options for pediatric Crohn's disease.A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine.Expression and Function of the Cholinergic System in Immune Cells.Pharmacogenetics of inflammatory bowel disease.A Potential 'Curative' Modality for Crohn's Disease---Modeled after Prophylaxis of Bovine Johne's Disease.Oral bismuth for chronic intractable diarrheal conditions?Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studies.How are Azathioprine and 6-mercaptopurine dosed by gastroenterologists? Results of a survey of clinical practice.Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
P2860
Q26864906-14D763E4-ED26-4761-9CA3-A491CB81C2C7Q26996946-ECC5101B-BE73-4AD3-88A7-8B8DE6CC820FQ30498145-5DD7850B-37EF-428E-8ED9-614B5CE6A34CQ33385516-89166267-8A5D-4A50-A8E4-A6D0E7C4C790Q33536129-042A3005-BD52-4FCB-B612-50A004FFF9D9Q34507117-D7EEE471-926D-4DFA-9C8F-88B7DF3E595FQ35231496-66041176-BA49-4063-8EFE-82B01EE9530DQ35649436-BAC819E6-93A9-4EA1-BA0A-B20CFC8D1121Q35693684-0C20D8A2-11FB-4320-BCDD-7178D65C173BQ35819552-8DCFC71C-5373-4811-A979-F9D39CB59EC8Q36441778-52E8B6B6-D34C-45B9-9829-49BCB6A59C9CQ36700777-8BA892BD-6ACE-47CC-8B55-1F00EC888304Q37058862-C0796027-5BB2-4790-BCD8-185157ED3204Q37149572-725414BB-9D9B-41CF-86C5-D3E954F64BA2Q37276962-32E6FE33-288B-4DEF-83C5-0EE586E08F1CQ37277894-103A63A4-3572-4900-B5DD-A058E832BC8DQ37345918-42C02CE3-FB5F-46E8-BDA0-42708E71516CQ37345925-A0CD8E73-140F-4C2C-B731-1D6CA19F5113Q37477531-0259E012-E9FF-4974-9981-0507A0A12AF8Q37620338-AFE7AE77-3DBF-4ECA-BC7E-A487F61BE024Q37662503-5A54955A-54AE-42D9-A918-74528DF93D05Q38197891-CC388A26-8563-4783-A1D6-1502900FFB61Q38323592-8A69F707-633C-4A6D-A3D8-E8C6C3D91832Q38501680-1D1C7F85-C899-451D-B394-A5127E44C58CQ38848140-0086CC12-4424-4CF7-9FF6-16E674EAF55CQ38883237-B7FFB9AD-D52A-4452-A7F0-D55CE862D1A3Q40460093-F68E4E58-9BA0-4D1B-96E4-64BB267393B5Q41440417-CA50B97E-CB22-4A2C-A2C3-D53C74E47131Q41673937-771941C7-7E83-42EF-B776-F06D8727BA3DQ41905099-3C1F645F-AED3-41C0-B54B-FEB2894C9135Q43225378-35C14192-7C86-4BAC-A236-E55EC8ADF07BQ43238855-C6FB3364-0921-441E-A559-7D59CD17CE2BQ46844594-DFDCA256-A498-4FDE-A23A-65E6D7F1412EQ50561961-5BCB9DD9-DC0F-4324-8D91-9A318116EE3D
P2860
Review article: practical management of inflammatory bowel disease patients taking immunomodulators.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Review article: practical mana ...... ients taking immunomodulators.
@ast
Review article: practical mana ...... ients taking immunomodulators.
@en
type
label
Review article: practical mana ...... ients taking immunomodulators.
@ast
Review article: practical mana ...... ients taking immunomodulators.
@en
prefLabel
Review article: practical mana ...... ients taking immunomodulators.
@ast
Review article: practical mana ...... ients taking immunomodulators.
@en
P2860
P1476
Review article: practical mana ...... ients taking immunomodulators.
@en
P2093
P2860
P356
10.1111/J.1365-2036.2005.02520.X
P407
P577
2005-07-01T00:00:00Z